KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr | ₹22 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹64 Cr |
Mar2023 | ₹69 Cr |
Mar2022 | ₹69 Cr |
Mar2021 | ₹73 Cr |
Mar2020 | ₹22 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹64 Cr | -6.76 | |
Mar2023 | ₹69 Cr | -0.59 | |
Mar2022 | ₹69 Cr | -5.51 | |
Mar2021 | ₹73 Cr | 233.68 | |
Mar2020 | ₹22 Cr | - |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹621.9 Cr | -0.8% | -1.4% | 9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | -0.8% |
-1.4% |
9.1% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses